Summary Aradigm has a unique pipeline in development targeting undertreated respiratory diseases. There is almost no coverage to be found on Aradigm. Wall Street has yet to discover this company, which is rare for a Phase III biotech stock. ... Seeking Alpha, 3 weeks ago
Parent-child interaction and oxytocin production in pre-schoolers with autism spectrum disorder [PAPERS]
, Ofer Golan , Yael Hirschler-Guttenberg , Sharon Ostfeld-Etzion and Ruth Feldman, PhD, Ofer Golan, PhD, Yael Hirschler-Guttenberg, MA, Sharon Ostfeld-Etzion, MA, Orna Zagoory-Sharon, PhD, Department of Psychology and the Gonda Brain ...British Journal of Psychiatry, 4 weeks ago
on your WebpageAdd Widget >Get your members hooked!